Table 4. Characteristics of 23 patients... | American Society of Hematology

Table 4.

Characteristics of 23 patients with local tumor invasiveness

							Outcomes
Patient no.	Age, y/sex	Sites of LTI	Stage	Tx	Response to Tx	Failure	Cause of death	OS (DFS), mo
1	54/M	Palate	I_EA	CTX	CR	L	DOD	15 (7)
2	64/F	Skin	I_EA	CTX	PD	L	DOD	4
3	52/M	Skull base	I_EA	CTX	PD	L, S	DOD	6
4	31/M	Lip	I_EB	CTX	PD	L	DOD	27
5	67/F	Palate	I_EB	CTX	PD	L, S	DOD	9
6	36/F	Eyelid	I_EB	CTX	PD	L	DOD	5
7	34/M	Eyelid	I_EA	CTX	NE	S	TRM	2
8	43/M	Skin	I_EA	CTX	PD	L, S	DOD	8
9	69/M	Palate	I_EB	CTX	PD	L, S	DOD	2
10	55/M	Skin	I_EB	CTX	PD	L, S	TRM	1
11	68/M	Ethmoid	II_EA	CTX	PD	L	DOD	16
12	46/F	Skin	II_EB	CTX	PR	L, S	DOD	11
13	42/M	Palate	II_EA	CTX	PD	L	DOD	5
14	41/M	Skull base	I_EA	CM	CR	S	DOD	40 (20)
15	61/M	Palate	I_EA	CM	CR	S	DOD	18 (4)
16	38/F	Palate	I_EA	CM	CR	S	DOD	14 (2)
17	18/M	Skin	II_EB	CM	PD	L	DOD	6
18	59/M	Lip	II_EA	CM	CR	S	DOD	65 (5)
19	24/M	Palate	II_EA	CM	CR	R	DOD	20 (3)
20	49/F	Maxilla	II_EB	CM	PD	S	TRM	5
21	52/F	Palate	II_EB	CM	CR	R, S	DOD	11 (1)
22	44/F	Skull base	II_EB	CM	CR	L, S	DOD	14 (2)
23	45/M	Palate	II_EA	CM	PD	L, S	DOD	14

							Outcomes
Patient no.	Age, y/sex	Sites of LTI	Stage	Tx	Response to Tx	Failure	Cause of death	OS (DFS), mo
1	54/M	Palate	I_EA	CTX	CR	L	DOD	15 (7)
2	64/F	Skin	I_EA	CTX	PD	L	DOD	4
3	52/M	Skull base	I_EA	CTX	PD	L, S	DOD	6
4	31/M	Lip	I_EB	CTX	PD	L	DOD	27
5	67/F	Palate	I_EB	CTX	PD	L, S	DOD	9
6	36/F	Eyelid	I_EB	CTX	PD	L	DOD	5
7	34/M	Eyelid	I_EA	CTX	NE	S	TRM	2
8	43/M	Skin	I_EA	CTX	PD	L, S	DOD	8
9	69/M	Palate	I_EB	CTX	PD	L, S	DOD	2
10	55/M	Skin	I_EB	CTX	PD	L, S	TRM	1
11	68/M	Ethmoid	II_EA	CTX	PD	L	DOD	16
12	46/F	Skin	II_EB	CTX	PR	L, S	DOD	11
13	42/M	Palate	II_EA	CTX	PD	L	DOD	5
14	41/M	Skull base	I_EA	CM	CR	S	DOD	40 (20)
15	61/M	Palate	I_EA	CM	CR	S	DOD	18 (4)
16	38/F	Palate	I_EA	CM	CR	S	DOD	14 (2)
17	18/M	Skin	II_EB	CM	PD	L	DOD	6
18	59/M	Lip	II_EA	CM	CR	S	DOD	65 (5)
19	24/M	Palate	II_EA	CM	CR	R	DOD	20 (3)
20	49/F	Maxilla	II_EB	CM	PD	S	TRM	5
21	52/F	Palate	II_EB	CM	CR	R, S	DOD	11 (1)
22	44/F	Skull base	II_EB	CM	CR	L, S	DOD	14 (2)
23	45/M	Palate	II_EA	CM	PD	L, S	DOD	14

Tx indicates treatment modality; M, male; CTX, chemotherapy alone; L, local failure; DOD, died of disease; F, female; PD, progressive disease; S, systemic failure; NE, not evaluable; TRM, treatment-related mortality; PR, partial remission; CM, combined modality; and R, regional failure.

View Large

This Feature Is Available To Subscribers Only